Search - Prime Therapeutics
Navigate to
-
NBC News: Patients weren't asked why they quit taking the weight loss drugs
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News -
Washington Post: Doctors and patients struggle with starting and stopping medications with little guidance.
PA Sub-Categories: GLP-1 Prime Article: In the News -
PUBLICATIONS FDA Decisions Expected: July 2025 Your monthly synopsis of new drugs expected to hit the market June 18, 2025 Drug pipeline for July 2025 At Prime Therapeutics (Prime), we have...
-
publications High-Cost Therapy Profile: November 2025 Tividenofusp alfa Intravenous (IV) | Denali Therapeutics Metabolic November 14, 2025 Proposed indications Mucopolysaccharidosis type II (MPS...
-
publications High-Cost Therapy Profile: June 2025 Zopapogene imadenovec Subcutaneous (SC) | Precigen, Inc. Infectious Disease June 18, 2025 Proposed indications Recurrent respiratory...
-
Marquee event showcased new Prime, our energy, ambition and transformative journey
PA Sub-Categories: Specialty drugs Prime Article: Perspectives -
Drug Approvals Quarterly Update: April 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....
-
Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care
Prime Article: Perspectives